Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-06-12

FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for Eli Lilly's insulin lispro product, updating regulatory status for the approved formulation. This action relates to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humalog (insulin lispro)

Snippet

SUPPL AP for INSULIN LISPRO (INSULIN LISPRO)